ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 234 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $69,141,000 | -5.9% | 2,397,396 | +3.8% | 0.01% | -9.1% |
Q3 2016 | $73,503,000 | +3.2% | 2,310,681 | +5.3% | 0.01% | -8.3% |
Q2 2016 | $71,220,000 | +21.7% | 2,194,087 | +4.8% | 0.01% | +20.0% |
Q1 2016 | $58,519,000 | -17.0% | 2,092,959 | +5.8% | 0.01% | -16.7% |
Q4 2015 | $70,537,000 | +12.7% | 1,978,601 | +4.6% | 0.01% | +9.1% |
Q3 2015 | $62,572,000 | -23.8% | 1,892,100 | -3.5% | 0.01% | -15.4% |
Q2 2015 | $82,145,000 | +4.0% | 1,961,442 | -19.1% | 0.01% | +8.3% |
Q1 2015 | $79,010,000 | +20.8% | 2,424,378 | +17.7% | 0.01% | +20.0% |
Q4 2014 | $65,424,000 | +24.7% | 2,060,610 | -2.7% | 0.01% | +11.1% |
Q3 2014 | $52,446,000 | +3.4% | 2,118,188 | -5.6% | 0.01% | +12.5% |
Q2 2014 | $50,697,000 | -6.4% | 2,244,208 | +0.9% | 0.01% | -11.1% |
Q1 2014 | $54,139,000 | +6.7% | 2,225,175 | +9.5% | 0.01% | 0.0% |
Q4 2013 | $50,763,000 | -7.5% | 2,031,321 | +1.7% | 0.01% | -18.2% |
Q3 2013 | $54,866,000 | +57.7% | 1,997,324 | +4.2% | 0.01% | +57.1% |
Q2 2013 | $34,784,000 | – | 1,916,464 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |